Story perspectives

U.S. Missionary Receives Experimental Ebola Pill, Antibody Cocktail in Germany

5/23/2026

Summary

Story summary

The infected missionary is receiving an experimental antiviral pill and an antibody cocktail abroad as part of his care.
Dr. Peter Stafford, a U.S. missionary, tested positive for Bundibugyo Ebola and is being treated in Germany.
Mapp Biopharmaceutical, the Biomedical Advanced Research and Development Authority (BARDA) and the World Health Organization (WHO) are preparing the experimental antibody cocktail MBP134, which protected most monkeys in trials, for the patient.

1 of 1

Story summary

The infected missionary is receiving an experimental antiviral pill and an antibody cocktail abroad as part of his care.
Dr. Peter Stafford, a U.S. missionary, tested positive for Bundibugyo Ebola and is being treated in Germany.
Mapp Biopharmaceutical, the Biomedical Advanced Research and Development Authority (BARDA) and the World Health Organization (WHO) are preparing the experimental antibody cocktail MBP134, which protected most monkeys in trials, for the patient.